Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

The Tumor Microenvironment02:17

The Tumor Microenvironment

6.7K
Every normal cell or tissue is embedded in a complex local environment called stroma, consisting of different cell types, a basal membrane, and blood vessels. As normal cells mutate and develop into cancer cells, their local environment also changes to allow cancer progression. The tumor microenvironment (TME) consists of a complex cellular matrix of stromal cells and the developing tumor. The cross-talk between cancer cells and surrounding stromal cells is critical to disrupt normal tissue...
6.7K

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Symptom burden in young adult brain tumor survivors: Key intervention targets based on patient-reported outcome network analyses.

Neuro-oncology practice·2026
Same author

Estimation of accumulated dose to organs at risk in head and neck cancer patients treated with scheduled replanning and dose painting in the ARTFORCE trial.

Physics and imaging in radiation oncology·2026
Same author

Acute and long-term toxicity profiles and final oncologic outcomes in the phase III ARTFORCE trial.

Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology·2026
Same author

Seizure prophylaxis in glioma surgery (SPRING): A multi-center, unblinded, randomized trial.

Neuro-oncology practice·2026
Same author

Intracranial hemorrhage in patients with primary brain cancer receiving anticoagulation.

Blood vessels, thrombosis & hemostasis·2026
Same author

Seizure prophylaxis in glioma surgery: a synopsis from the SPRING RCT.

Health technology assessment (Winchester, England)·2026

Related Experiment Video

Updated: Aug 7, 2025

Quantitative Immunohistochemistry of the Cellular Microenvironment in Patient Glioblastoma Resections
05:45

Quantitative Immunohistochemistry of the Cellular Microenvironment in Patient Glioblastoma Resections

Published on: July 31, 2017

9.7K

Transcriptome analysis reveals tumor microenvironment changes in glioblastoma.

Youri Hoogstrate1, Kaspar Draaisma2, Santoesha A Ghisai1

  • 1Department of Neurology, Erasmus Medical Center, 3015GD Rotterdam, the Netherlands.

Cancer Cell
|March 10, 2023
PubMed
Summary

Glioblastoma evolution primarily involves microenvironment changes, not tumor cell mutations. Recurrent tumors show increased extracellular matrix genes linked to worse survival, highlighting the importance of the tumor microenvironment in glioblastoma progression.

Keywords:
RNA-seqextracellular matrixglioblastomaneuronspericytesrecursive correlationsingle-nucleus RNA-seqtumor evolution

More Related Videos

Digital Spatial Profiling for Characterization of the Microenvironment in Adult-Type Diffusely Infiltrating Glioma
09:17

Digital Spatial Profiling for Characterization of the Microenvironment in Adult-Type Diffusely Infiltrating Glioma

Published on: September 13, 2022

2.4K
Characterization of Functionally Associated miRNAs in Glioblastoma and their Engineering into Artificial Clusters for Gene Therapy
09:40

Characterization of Functionally Associated miRNAs in Glioblastoma and their Engineering into Artificial Clusters for Gene Therapy

Published on: October 4, 2019

5.7K

Related Experiment Videos

Last Updated: Aug 7, 2025

Quantitative Immunohistochemistry of the Cellular Microenvironment in Patient Glioblastoma Resections
05:45

Quantitative Immunohistochemistry of the Cellular Microenvironment in Patient Glioblastoma Resections

Published on: July 31, 2017

9.7K
Digital Spatial Profiling for Characterization of the Microenvironment in Adult-Type Diffusely Infiltrating Glioma
09:17

Digital Spatial Profiling for Characterization of the Microenvironment in Adult-Type Diffusely Infiltrating Glioma

Published on: September 13, 2022

2.4K
Characterization of Functionally Associated miRNAs in Glioblastoma and their Engineering into Artificial Clusters for Gene Therapy
09:40

Characterization of Functionally Associated miRNAs in Glioblastoma and their Engineering into Artificial Clusters for Gene Therapy

Published on: October 4, 2019

5.7K

Area of Science:

  • Oncology
  • Genomics
  • Neuroscience

Background:

  • Understanding transcriptional evolution in IDH-wild-type glioblastoma is key for treatment optimization.
  • Current standard of care treatments are used in patients with paired primary-recurrent glioblastoma resections.

Purpose of the Study:

  • To investigate the transcriptional changes and evolution of IDH-wild-type glioblastoma from primary to recurrent stages.
  • To identify molecular mechanisms driving glioblastoma recurrence and their impact on patient survival.

Main Methods:

  • RNA sequencing (RNA-seq) on 322 primary-recurrent glioblastoma samples for validation and 245 for testing.
  • Analysis of transcriptional subtypes, gene expression alterations, and tumor microenvironment composition.
  • Confirmation of findings using single-cell RNA-seq and immunohistochemistry.

Main Results:

  • Transcriptional subtypes form a continuum; recurrent tumors exhibit mesenchymal progression.
  • Tumor purity decreases over time, with increases in neuron, oligodendrocyte, and macrophage markers, and decreases in endothelial markers.
  • An extracellular matrix gene set increases at recurrence, mainly expressed by pericytes, and is associated with worse survival.

Conclusions:

  • Glioblastoma evolution is driven primarily by microenvironment reorganization rather than molecular evolution of tumor cells.
  • Pericyte-associated extracellular matrix gene expression at recurrence signifies a poor prognostic marker.
  • Targeting microenvironment changes may offer new therapeutic strategies for glioblastoma.